Section II:New Technologies and New Products——Session 2:Efficacy and Evidence-Based Applications of Ergothioneine |
2026-03-14 09:00-12:00 Dongyu,Hesheng room(Wanquan Ballroom 1/3) |
Moderator：He Tao,Deputy Director,Key Laboratory of Food Nutrition and Health Evaluation Technology,State Administration for Market Regulation |
| 2026-03-14 09:00-09:20 Synthetic biology of ergothioneine in edible mushrooms and its anti-aging effects |
| 2026-03-14 09:20-09:40 Dr.Ergo® Ergothioneine:Re-establishing the Value of the 5th-Generation Smart Antioxidants Based on Clinical Evidence |
| 2026-03-14 09:40-10:00 Synergistic Inhibition of Acrolein Activity by Ergothioneine and GABA:In Vitro and In Vivo Studies |
| 2026-03-14 10:00-10:20 Redefining Dietary Supplements with Evidence-Based Science and Human Clinical Evidence |
| 2026-03-14 10:20-10:40 The protective effect of ergothioneine on oxidative damage of nerve cells |
| 2026-03-14 10:40-11:00 Ergothioneine:Efficacy Research and Regulatory Status |
| 2026-03-14 11:00-11:55 Roundtable Meeting：The Development Path of Ergothioneine in ChinaModerator: |
| 2026-03-14 11:55-12:00 |
